Smith-Van Vurst Andrew
SMITH-VAN VURST ANDREW, COO, reported a transaction classified as exercise at BioStem Technologies, Inc. involving 7622.000000 shares for an estimated $0.00. Reported holdings after the transaction were 1530235.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 15, 2026
- Filing date
- Sep 17, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
BSEM price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001193125-26-394391 Common Stock
- Transaction date
- Sep 15, 2026 Filed Sep 17, 2026, 08:30 PM · 2d delay
- Shares
- 7,622 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 1,530,235 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Operating Officer
- F1
These options are fully vested and exercisable.
- F2
These options vest according to the following schedule: 33% vested on March 17, 2026, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installments ove…
- F3
These options vest according to the following schedule: 33%% will vest on October 13, 2026, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installmen…
- F4
These options vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installmen…
- F5
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F6
These restricted stock units will vest in equal quarterly installments over three years from the grant date (September 15, 2024).
- F7
These restricted stock units vest according to the following schedule: 33% vested on March 17, 2026, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly ins…
- F8
These restricted stock units vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarter…
0 other transactions
0 recent txs